Ming-Wei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ming-Wei Wang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Bing Han
Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang 050031, Hebei, PR China
3 shared publicationsHua-Long Wang
Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang 050031, Hebei, PR China
3 shared publicationsYuan Geng
Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang 050031, Hebei, PR China
3 shared publicationsHualong Wang
Department of Neurology, the first hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
2 shared publicationsJing Qiang
Department of Neurology, the first hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
2 shared publicationsMeiyu Sun
Department of Neurology, the first hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
2 shared publications
Latest Publications
- 1 March 2017
- Published by Elsevier in Behavioural Brain Research
- Vol. 321, 209-213
Age-related alterations of neuronal excitability and voltage-dependent Ca 2+ current in a spontaneous mouse model of Alzheimer’s disease
- 1 March 2017
- Published by Elsevier in Behavioural Brain Research
- Vol. 321, 209-213
Age-related alterations of neuronal excitability and voltage-dependent Ca 2+ current in a spontaneous mouse model of Alzheimer’s disease
- 27 February 2016
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 51 (1) , 45-55
Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer’s Disease: A Meta-Analysis
Abnormal cholesterol metabolism is an established feature of Alzheimer’s disease (AD). Cerebrospinal fluid (CSF) is the fluid surrounding the central nervous system, and the protein and lipid content alterations in the CSF could be biomarkers for deg
- 27 February 2016
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 51 (1) , 45-55
Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer’s Disease: A Meta-Analysis
Abnormal cholesterol metabolism is an established feature of Alzheimer’s disease (AD). Cerebrospinal fluid (CSF) is the fluid surrounding the central nervous system, and the protein and lipid content alterations in the CSF could be biomarkers for deg
- 1 February 2015
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 118, 1-7
Chronic high-frequency repetitive transcranial magnetic stimulation improves age-related cognitive impairment in parallel with alterations in neuronal excitability and the voltage-dependent Ca2+ current in female mice
- 1 February 2015
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 118, 1-7
Chronic high-frequency repetitive transcranial magnetic stimulation improves age-related cognitive impairment in parallel with alterations in neuronal excitability and the voltage-dependent Ca2+ current in female mice
- 14 February 2014
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 39 (4) , 841-848
Age-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model
Alzheimer's disease (AD), the most common age-dependent neurodegenerative disorder, produces a progressive decline in cognitive function. The metabolic mechanism of AD has emerged in recent years. In this study, we used multivariate analyses of gas c
- 14 February 2014
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 39 (4) , 841-848
Age-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model
Alzheimer's disease (AD), the most common age-dependent neurodegenerative disorder, produces a progressive decline in cognitive function. The metabolic mechanism of AD has emerged in recent years. In this study, we used multivariate analyses of gas c
- Open Access
- 22 November 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11) , e81482
Repetitive Transcranial Magnetic Stimulation Applications Normalized Prefrontal Dysfunctions and Cognitive-Related Metabolic Profiling in Aged Mice
Chronic high-frequency repetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation technique that has recently received increasing interests as a therapeutic procedure for neurodegenerative diseases. To identify the metabolism mechanism underlying the improving effects of rTMS, we observed that high frequency (25Hz) rTMS for 14 days could reverse the decline of the performance of the passive avoidance task in aged mice. We further investigated the metabolite profiles in the prefrontal cortex (PFC) in those mice and found that rTMS could also reverse the metabolic abnormalities of gamma-aminobutyric acid, N-acetyl aspartic, and cholesterol levels to the degree similar to the young mice. These data suggested that the rTMS could ameliorate the age-related cognitive impairment and improving the metabolic profiles in PFC, and potentially can be used to improve cognitive decline in the elderly.
- 22 November 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11) , e81482
Open AccessRepetitive Transcranial Magnetic Stimulation Applications Normalized Prefrontal Dysfunctions and Cognitive-Related Metabolic Profiling in Aged Mice
Chronic high-frequency repetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation technique that has recently received increasing interests as a therapeutic procedure for neurodegenerative diseases. To identify the metabolism mechanism underlying the improving effects of rTMS, we observed that high frequency (25Hz) rTMS for 14 days could reverse the decline of the performance of the passive avoidance task in aged mice. We further investigated the metabolite profiles in the prefrontal cortex (PFC) in those mice and found that rTMS could also reverse the metabolic abnormalities of gamma-aminobutyric acid, N-acetyl aspartic, and cholesterol levels to the degree similar to the young mice. These data suggested that the rTMS could ameliorate the age-related cognitive impairment and improving the metabolic profiles in PFC, and potentially can be used to improve cognitive decline in the elderly.